Company profile: Agilent
1.1 - Company Overview
Company description
- Provider of scientific and laboratory management solutions for analytical scientists and clinical researchers, offering instruments, software, and HPLC, GC & spectroscopy supplies for chemical analysis; life sciences tools for genomics, proteomics, and cell analysis; diagnostic solutions including pathology and molecular diagnostics; and products such as 8850 GC and NovoCyte Opteon.
Products and services
- Chemical Analysis: Laboratory-grade instruments and software engineered for diverse laboratory applications, spanning high-performance liquid chromatography, gas chromatography, and spectroscopy workflows, with precision-engineered supplies ensuring reliable performance
- Diagnostics: Clinical-grade pathology and molecular diagnostics systems for clinical laboratories, architected for routine clinical workflows and aligned with laboratory management needs of analytical scientists and clinical researchers
- Life Sciences: Research-grade products and services for genomics, proteomics, and cell analysis, including a flow cytometry system capable of handling complex panels with multiple colors for advanced studies
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Agilent
Microchips Biotech
HQ: United States
Website
- Description: Provider of a proprietary microchip-based implant for long-term, precise drug delivery. The subcutaneous device stores and releases exact doses over months and years and is placed under the skin by a trained physician in a simple office procedure using local anesthesia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Microchips Biotech company profile →
Irvine Scientific
HQ: United States
Website
- Description: Provider of cell culture media, reagents, and medical devices for researchers and clinicians in bioproduction, vaccines, cell and gene therapies, regenerative medicine, and assisted reproductive technologies. Products include chemically defined CHO, NK, and T cell media, embryo culture oil, DMSO-free cryopreservation, and bone marrow culture media.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Irvine Scientific company profile →
Ziylo
HQ: United Kingdom
Website
- Description: Provider of biomimetic glucose binding molecules (GBM) based on supramolecular chemistry for use in diabetes care, enabling Continuous Glucose Monitors (CGM) and Glucose Responsive Insulins (GRI), with a mission to help people with diabetes live more normal and longer lives.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ziylo company profile →
Microbia
HQ: United States
Website
- Description: Provider of industrial biotechnology, developing, producing, and commercializing fermentation-based specialty ingredients and biomaterials, including carotenoids, biopolymers, and other biomaterials; maintains a strategic alliance with Tate & Lyle Investments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Microbia company profile →
Nanna Therapeutics
HQ: United Kingdom
Website
- Description: Provider of drug discovery platforms targeting fundamental cellular processes in age-related diseases. Offers the Nanoscale Medicines Discovery Engine for novel drugs addressing mitochondrial dysfunction and the Totally Integrated Medicines Engine (TIME), conducting 100 million phenotypic assays per hour to identify small-molecule leads for mitochondrial, neurodegenerative, cardiovascular/metabolic, joint/tissue diseases and cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanna Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Agilent
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Agilent
2.2 - Growth funds investing in similar companies to Agilent
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Agilent
4.2 - Public trading comparable groups for Agilent
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →